H. Egídio Group, through HT3 Investimentos, has invested in Central da Visão, a leading Brazilian healthtech firm, to enhance its involvement in the healthcare sector and expand technological and operational capabilities in ophthalmological surgeries.

Target Company Overview

The Central da Visão is a Brazilian healthtech company established in 2017 that specializes in providing affordable ophthalmological surgeries by utilizing idle capacity in private clinics. Since its inception in São Paulo, it has expanded to over 50 affiliated clinics and boasts a network of 200 ophthalmic surgeons across 14 Brazilian states. With a focus on scalability through technology, the organization has successfully completed more than 20,000 surgeries, positioning itself as a leader in its sector.

This investment aligns with the company’s mission to enhance patient access to high-quality eye care, emphasizing efficiency in surgical processes and affordability while maintaining superior medical standards.

Industry Overview in Brazil

Brazil's healthcare sector has undergone significant transformations in recent years, largely driven by technological advancements and heightened demand for quality medical services. The rise of healthtech companies reflects an increasi